Authors: LUNDIN J OSTERBORG A BRITTINGER G CROWTHER D DOMBRET H ENGERT A EPENETOS A GISSELBRECHT C HUHN D JAEGER U THOMAS J MARCUS R NISSEN N POYNTON C RANKIN E STAHEL R UPPENKAMP M WILLEMZE R MELLSTEDT H

Citation: J. Lundin et al., CAMPATH-1H MONOCLONAL-ANTIBODY IN THERAPY FOR PREVIOUSLY TREATED LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II MULTICENTER STUDY, Journal of clinical oncology, 16(10), 1998, pp. 3257-3263

Authors: COLEMAN M RAFLA S PROPERT KJ GLICKSMAN A PETERSON B NISSEN N BRUNNER K HOLLAND JF ANDERSON JR GOTTLIEB A KAUFMAN T

Citation: M. Coleman et al., AUGMENTED THERAPY OF EXTENSIVE HODGKINS-DISEASE - RADIATION TO KNOWN DISEASE OR PROLONGATION OF INDUCTION CHEMOTHERAPY DID NOT IMPROVE SURVIVAL - RESULTS OF A CANCER AND LEUKEMIA GROUP-B STUDY, International journal of radiation oncology, biology, physics, 41(3), 1998, pp. 639-645

Authors: OSTERBORG A DYER MJS BUNJES D PANGALIS GA BASTION Y CATOVSKY D MELLSTEDT H RANKIN E TSEKOURAS C PANGALIS GA CAVALLI F SESSA C HUHN D MARCUS R MAUGHAN T POYNTON C NISSEN N CARNEY D BRITTINGER G UPPENKAMP M ELONEN E TEERENHOVI L",ENGERT,"WILLEMZE R KLUINNELEMANS J THOMAS J EPENETOS AA NETHERSELL A DYER M CATOVSKY D DICATO M BASTION Y COIFFIER B RANADA JMF CROWTHER D WOLL P RAEMAKAERS J DEPAUW B DEGOS L",GISSELLBRECHT,"REIFFERS J MELLSTEDT H FASSAS A ANAGNOSTOPOULOS A BUNJES D JAEGER U STAHEL RA

Citation: A. Osterborg et al., PHASE-II MULTICENTER STUDY OF HUMAN CD52 ANTIBODY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 15(4), 1997, pp. 1567-1574

Authors: MADER H GUARNIERI A DOOSE J NISSEN N MARKOV VN SHTANYUK AM ANDRIANOV AF SHANIN VN KRUPNOV AF

Citation: H. Mader et al., COMPARATIVE-STUDIES OF J'[-J=1[-0 CO LINE PARAMETERS IN FREQUENCY ANDTIME DOMAINS, Journal of molecular spectroscopy, 180(1), 1996, pp. 183-187

Authors: HASSELBALCH H HOVGAARD D NISSEN N JUNKER P

Citation: H. Hasselbalch et al., SERUM HYALURONAN IS INCREASED IN MALIGNANT-LYMPHOMA, American journal of hematology, 50(4), 1995, pp. 231-233